Warning: The NCBI web site requires JavaScript to function. more...
Impact of tumour volume on the potential efficacy of therapeutic vaccines.
Gulley JL, Madan RA, Schlom J.
Curr Oncol. 2011 Jun;18(3):e150-7.
Related citations
Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21.
Mackay HJ, Provencheur D, Heywood M, Tu D, Eisenhauer EA, Oza AM, Meyer R.
Curr Oncol. 2011 Apr;18(2):84-90.
Clinical implications of next-generation sequencing for cancer medicine.
Shuen A, Foulkes WD.
Curr Oncol. 2010 Oct;17(5):39-42. No abstract available.
The role of photopheresis in the treatment of graft-versus-host disease.
Klassen J.
Curr Oncol. 2010 Apr;17(2):55-8. No abstract available.
Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer.
Kraeber-Bodéré F, Goldenberg DM, Chatal JF, Barbet J.
Curr Oncol. 2009 Sep;16(5):3-8. No abstract available.
Microbes and colorectal cancer: is there a relationship?
Uronis JM, Jobin C.
Curr Oncol. 2009 Aug;16(4):22-4. No abstract available.
Exosomes in tumour immunity.
Clayton A, Mason MD.
Curr Oncol. 2009 May;16(3):46-9. No abstract available.
Electrochemotherapy of tumours.
Sersa G, Cemazar M, Snoj M.
Curr Oncol. 2009 Mar;16(2):34-5. No abstract available.
Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics.
Williams PD, Lee JK, Theodorescu D.
Curr Oncol. 2009 Jan;16(1):56-8.
Cancer and thrombosis: recent advances.
Solymoss S.
Curr Oncol. 2008 Dec;15(6):302-3. No abstract available.
Anal cancer and human papillomaviruses in heterosexual men.
Nyitray A.
Curr Oncol. 2008 Oct;15(5):204-5. No abstract available.
Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
Bonfil RD, Fridman R, Mobashery S, Cher ML.
Curr Oncol. 2008 Aug;15(4):188-92. No abstract available.
Protein tyrosine phosphatases: new markers and targets in oncology?
Hardy S, Tremblay ML.
Curr Oncol. 2008 Jan;15(1):5-8. No abstract available.
The antitumour activities of statins.
Takahashi HK, Nishibori M.
Curr Oncol. 2007 Dec;14(6):246. No abstract available.
Role of vaccine therapy in cancer: biology and practice.
Schlom J, Gulley JL, Arlen PM.
Curr Oncol. 2007 Dec;14(6):238-45.
Radiation oncology: times of practice change.
Freeman CR, Podgorsak EB.
Curr Oncol. 2007 Oct;14(5):165-6. No abstract available.
Cancer symptom control trials: how may we advance this field?
Macdonald N.
Curr Oncol. 2007 Jun;14(3):86-8. No abstract available.
Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6.
Chan CH, Stanners CP.
Curr Oncol. 2007 Apr;14(2):70-3. No abstract available.
Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies.
Jiang WG.
Curr Oncol. 2007 Apr;14(2):66-9. No abstract available.
Radiolabelled monoclonal antibodies in the treatment of metastatic cancer.
Goldenberg DM.
Curr Oncol. 2007 Feb;14(1):39-42. No abstract available.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on